VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: j bayer who wrote (6939)	4/13/1998 10:01:00 PM
From: VLAD	Read Replies (1) of 23519

Good News for Vivus! Zacks increases Q2 estimates to .14 and FY '98 to .80. Also an upgrade from buy to strong buy. At todays closing price Vivus has a forward PE of 11. A reasonable PE of 20 would give us a price of 16. An average drug stock PE of 30 would give us a price of 24. I predict a buy out (Maybe Johnson and Johnson?) if Vivus stays at these levels for a prolonged span of time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next